Eris Lifesciences Limited
ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products.
What Eris files
- Investor Meet48
- Others48
- Important27
- Board Meeting18
- PPTs8
- Updates7
Eris Lifesciences has announced that Krishnakumar Vaidyanathan has resigned from his position as Executive Director and Chief Operating Officer to pursue professional opportunities outside the organization. The leadership transition will take effect at the close of business hours on September 30, 2026. This exit of a key member of the...
Eris Lifesciences has issued a clarification regarding recent media reports and news articles covering its earlier disclosures. The company has explicitly stated that investors must disregard incorrect figures circulating externally and rely solely on the accurate loan values provided in its official exchange filings. This clarification ensures market transparency and...
Eris Lifesciences has partnered with Axis Bank for a term loan of ₹45 Cr to cover liabilities, secured by company brands. This routine financial adjustment keeps net debt neutral while supporting operational liquidity.
Eris Lifesciences Limited has informed the Exchange about Schedule of meet
Eris Lifesciences Limited has informed the Exchange about Copy of Newspaper Publication